Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-034587
Filing Date
2025-03-06
Accepted
2025-03-06 16:04:54
Documents
108
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acet-20241231.htm   iXBRL 10-K 4073656
2 EX-4.1 acet-ex4_1.htm EX-4.1 45519
3 EX-10.11 acet-ex10_11.htm EX-10.11 4905
4 EX-23.1 acet-ex23_1.htm EX-23.1 3248
5 EX-31.1 acet-ex31_1.htm EX-31.1 18631
6 EX-31.2 acet-ex31_2.htm EX-31.2 18403
7 EX-32.1 acet-ex32_1.htm EX-32.1 9319
8 GRAPHIC img105755451_0.jpg GRAPHIC 111349
9 GRAPHIC img105755451_1.jpg GRAPHIC 278314
10 GRAPHIC img105755451_2.jpg GRAPHIC 208717
  Complete submission text file 0000950170-25-034587.txt   15800931

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20241231.xsd EX-101.SCH 2359781
111 EXTRACTED XBRL INSTANCE DOCUMENT acet-20241231_htm.xml XML 2062779
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38359 | Film No.: 25715167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)